Research HubResearch
Aesthetic 7 min readSep 2026

GHK-Cu: Copper-Binding Tripeptide Research in Skin and Wound Biology

A research overview of GHK-Cu, a naturally occurring copper-binding tripeptide studied for its effects on collagen remodeling, gene expression, and wound repair.

GHK-Cu (glycyl-L-histidyl-L-lysine, complexed with copper(II)) is a naturally occurring tripeptide first isolated from human plasma in 1973, where it was noted to decline substantially with age — from roughly 200 ng/mL in young adults to a fraction of that by the sixth decade. This age-related decline, combined with its high-affinity copper-chelating structure, is what originally directed research attention toward its role in tissue maintenance and repair, and it remains one of the more mechanistically well-characterized peptides in the dermal-research literature.

Copper Chelation Chemistry

The tripeptide's glycine-histidine-lysine sequence forms a square-planar coordination complex with Cu²⁺ with high binding affinity, involving the imidazole nitrogen of histidine, the terminal amino group, and a peptide backbone nitrogen. This is not incidental to the molecule's biological activity — copper is a required cofactor for lysyl oxidase (which cross-links collagen and elastin), for superoxide dismutase (an antioxidant enzyme), and for cytochrome c oxidase in mitochondrial respiration. GHK-Cu is understood in the research literature primarily as a copper-delivery and copper-trafficking vehicle whose biological effects are difficult to separate from copper's own enzymatic roles.

Gene Expression Findings

GHK-Cu is one of the more extensively profiled peptides in connective-tissue transcriptomic research. Broad gene-expression microarray studies in human fibroblast and skin models report GHK-Cu modulating several hundred genes, with notable upregulation clusters in collagen types I and III, matrix metalloproteinases balanced against their tissue inhibitors (TIMPs), and antioxidant-response genes. This broad transcriptional footprint is the basis for GHK-Cu's reputation in the literature as a "tissue remodeling signal" rather than a single-pathway agent — though the breadth of the effect also makes isolating a primary mechanism of action more difficult than for more receptor-specific peptides.

  • Stimulates collagen and glycosaminoglycan synthesis in fibroblast culture models, supporting extracellular matrix research applications.
  • Modulates matrix metalloproteinase (MMP) and TIMP expression in a pattern research literature associates with balanced remodeling rather than net degradation.
  • Shows chemotactic effects on macrophages and mast cells in wound-model research, consistent with a role in early inflammatory-phase repair signaling.
  • Exhibits antioxidant activity attributed both to its own radical-scavenging capacity and to copper-dependent superoxide dismutase support.

Wound Healing Models

Animal wound-healing research is where GHK-Cu has the longest track record. In rodent excisional and incisional wound models, topical or local GHK-Cu application is repeatedly associated with accelerated healing timelines, increased wound-breaking strength, and improved angiogenesis in the healing bed relative to controls. Proposed contributing mechanisms include the chemotactic recruitment of immune cells noted above, stimulated collagen deposition, and copper-dependent angiogenic signaling via effects on endothelial cell migration.

Hair Follicle and Dermal Research

A separate research strand examines GHK-Cu's effects on hair follicle biology, based on its capacity to stimulate follicle stem cell proliferation and modulate the anagen (growth) phase of the hair cycle in animal and ex vivo human scalp models. As with the broader dermal literature, effect sizes vary considerably across study designs, delivery methods, and concentrations, and comparative research against established reference compounds remains limited.

GHK-Cu solutions are prone to oxidative degradation distinct from typical peptide bond hydrolysis — free copper ions can catalyze oxidation of the peptide backbone and of other components in a formulation if the complex dissociates. Research protocols generally recommend protecting reconstituted GHK-Cu from light and prolonged room-temperature exposure, and avoiding co-formulation with reducing agents that could destabilize the copper coordination complex.

Related Research

Aesthetic
Melanotan II: Melanocortin Receptor Pharmacology and Research History
Recovery
BPC-157: Mechanisms of Action and Research Applications
Metabolic
Understanding GLP-1 Receptor Agonists in Metabolic Research